by Debi Vinnedge | May 11, 2009 | Archive, News, Stem Cell Research
As Reported By LifeNews.com May 11, 2009 Pfizer Signs With Wisconsin Group to Use Embryonic Stem Cells for Drugs Madison, WI (LifeNews.com) — Embryonic stem cells have produced serious problems when used in animals and have never been tried in humans, yet alone...
by Yvonne Bontkowski | Jan 10, 2025 | Abortion, Fetal & Vaccine Research, News, Vaccines
The FDA issued a Safety Communication in recent days regarding the two RSV Vaccines Arexvy (GSK) and Abrysvo (Pfizer) which were approved in 2023. Both vaccines made the naughty list as they used a modfied HEK aborted fetal cell line. The FULL chart of all tainted...
by Jose Trasancos | Sep 21, 2023 | Abortion, Fetal & Vaccine Research, Vaccines
Two RSV (Respiratory Syncytial Virus) vaccines have been approved in 2023 – Arexvy (GSK) and Abrysvo (Pfizer). Arexvy is recommended for adults over 60 years of age and Abrysvo has also been recommended for administration to expectant mothers between 32 and 36...
by Jose Trasancos | Oct 21, 2022 | Abortion, Exemptions, News, Vaccines
The CDC’s Advisory Committee voted yesterday, October 20th, 2022, endorsing the addition of Covid-19 vaccines to the CDC’s Vaccination Schedule. The endorsement affects childhood and adult vaccination schedules, and the vote was unanimous in support of...
by Jose Trasancos | Mar 2, 2022 | Abortion, International, Legislative, News, Vaccines
These vaccine candidates have been in the news lately, and we’ve received a number of inquiries with respect to their ethics and potential availability. Let’s address these questions. Corbevax Corbevax made the news in late December of last year, following its...
